Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors

Primary lung epithelial malignancies are the most common neoplasms among all pulmonary tumors. Lung cancer (LC) is the leading cause of cancer-related mortality for which a histologic or cytologic confirmation of malignancy is required before treatment. Specimen management is an important task for p...

Descripción completa

Detalles Bibliográficos
Autor principal: Jain, Deepali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060582/
https://www.ncbi.nlm.nih.gov/pubmed/30089951
http://dx.doi.org/10.4103/JOC.JOC_73_18
_version_ 1783342063571435520
author Jain, Deepali
author_facet Jain, Deepali
author_sort Jain, Deepali
collection PubMed
description Primary lung epithelial malignancies are the most common neoplasms among all pulmonary tumors. Lung cancer (LC) is the leading cause of cancer-related mortality for which a histologic or cytologic confirmation of malignancy is required before treatment. Specimen management is an important task for pathologists in the field of LC. Biopsy and fine needle aspiration are comparable. It is desirable to have both for diagnosis and mutation testing to maximize their use for patient care.
format Online
Article
Text
id pubmed-6060582
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-60605822018-08-08 Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors Jain, Deepali J Cytol Symposium Primary lung epithelial malignancies are the most common neoplasms among all pulmonary tumors. Lung cancer (LC) is the leading cause of cancer-related mortality for which a histologic or cytologic confirmation of malignancy is required before treatment. Specimen management is an important task for pathologists in the field of LC. Biopsy and fine needle aspiration are comparable. It is desirable to have both for diagnosis and mutation testing to maximize their use for patient care. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC6060582/ /pubmed/30089951 http://dx.doi.org/10.4103/JOC.JOC_73_18 Text en Copyright: © 2018 Journal of Cytology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Symposium
Jain, Deepali
Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
title Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
title_full Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
title_fullStr Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
title_full_unstemmed Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
title_short Tru-cut/core Biopsy versus FNAC: Pulmonary Tumors
title_sort tru-cut/core biopsy versus fnac: pulmonary tumors
topic Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060582/
https://www.ncbi.nlm.nih.gov/pubmed/30089951
http://dx.doi.org/10.4103/JOC.JOC_73_18
work_keys_str_mv AT jaindeepali trucutcorebiopsyversusfnacpulmonarytumors

Ejemplares similares